The Direct Standard secures transport—not disclosure authority

Direct is a secure push-transport pattern

The Direct Standard addresses sending health information to a known recipient through a profiled secure-messaging path. The operating chain includes sender and recipient addresses, certificates, trust, message construction, transport, delivery status, and audit evidence.

That model differs from a query network, a FHIR API, a bulk-data export, or an event-subscription service. Each can participate in health-information exchange, but the exchange purpose, actors, identity, authorization, discovery, response, and exception patterns are not interchangeable.

Transport security and disclosure authority are separate

Secure and authenticated transport can establish properties of the message path. It does not decide whether the sender is permitted or required to disclose the information, whether the recipient is the correct party for the stated purpose, or whether segmentation and minimum-necessary decisions were handled appropriately.

A buyer should identify which system and accountable role establish identity, relationship, purpose of use, patient matching, consent or other authorization context, sensitive-data handling, and release approval. Those facts should be linked to the message without being represented as products of the transport standard itself.

Delivery is not reconciliation

A delivery notification can support an operational record that the message reached a point in the transport chain. It cannot establish that the document was complete, parsed correctly, matched to the right patient, reviewed by the intended person, reconciled into the record, or used in care.

Implementation testing should follow a representative referral or transition through composition, addressing, certificate and trust checks, delivery, failure handling, receipt, patient matching, document handling, reconciliation, and audit. The test should preserve where Direct ends and the receiving workflow begins.

Version and evidence state remain explicit

The official record identifies Version 1.3 and its ANSI designation. Buyers should require the product, service, or network claim to name the supported version and distinguish documentation, certification, testing, available connectivity, and production use.

A provider statement that it supports Direct is not evidence of universal recipient reach, production reliability, disclosure compliance, data quality, or clinical outcome. Those conclusions need their own environment, population, period, method, exceptions, and accountable source.

Enterprise buyer test

Translate this change into the exact population, record type, workflow stage, decision owner, effective date, and evidence that could be affected. Ask current or prospective providers to demonstrate the named workflow with representative data and an exception—not a polished feature tour. Record what official documentation establishes, what a provider states, what the team observes, and what remains unresolved.

A defensible review also identifies the dependency outside the product. Authority interpretation, policy configuration, data quality, integrations, human judgment, approval rights, release governance, training, and retained evidence may remain customer or service responsibilities. The evaluation should preserve those boundaries instead of treating a technology claim as the complete operating model.

What we will watch next

Health Interoperability Review will watch the named source and affected market records for later evidence that changes status, scope, availability, implementation timing, workflow consequence, or the limits of the initial report. A later announcement does not silently overwrite this dated account; the change ledger preserves the sequence.